| Compound Information | SONAR Target prediction |
| Name: | RIFAMPIN |
| Unique Identifier: | SPE01500529 |
| MolClass: | Checkout models in ver1.5 and ver1.0 |
| Molecular Formula: | |
| Molecular Weight: | 764.48 g/mol |
| X log p: | 11.905 (online calculus) |
| Lipinksi Failures | 2 |
| TPSA | 106.97 |
| Hydrogen Bond Donor Count: | 0 |
| Hydrogen Bond Acceptors Count: | 16 |
| Rotatable Bond Count: | 5 |
| Canonical Smiles: | COC1C=COC2(C)Oc3c(C)c(O)c4c(O)c(NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(O
C(C)=O)C1C)c(C=NN1CCN(C)CC1)c(O)c4c3C2=O |
| Source: | semisynthetic; L-5103, Ba-41166/E, NSC-113926 |
| Therapeutics: | antibacterial (tuberculostatic) |
| Generic_name: | RIFAMPICIN |
| Chemical_iupac_name: | RIFAMPICIN |
| Drug_type: | Experimental |
| Kegg_compound_id: | C06688 |
| Drugbank_id: | EXPT02777 |
| Logp: | 3.719 |
| Cas_registry_number: | 13292-46-1 |
| Drug_category: | Orphan Nuclear Receptor Pxr inhibitor |
| Organisms_affected: | -1 |
